MPX-004

Modify Date: 2024-01-30 14:34:13

MPX-004 Structure
MPX-004 structure
Common Name MPX-004
CAS Number 1688684-07-2 Molecular Weight 455.91
Density N/A Boiling Point N/A
Molecular Formula C17H15ClFN5O3S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of MPX-004


MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].

 Names

Name MPX-004

 MPX-004 Biological Activity

Description MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].
Related Catalog
Target

NMDA Receptor

In Vitro MPX-004 抑制表达人 GluN1+GluN2A 的 Xenopus 卵母细胞中 NMDA 受体介导的电流,IC50 为 198 nM。在 10 μM 时,MPX-004 仅微弱地抑制表达 GluN2B、C 或 D 受体的卵母细胞或对照卵母细胞中的电流 (约8%)[1]。 MPX-004 (100 nM-30 μM; 0-50 分钟) 在 3 至 4 周龄大鼠大脑制备的海马切片导致 CA1 区 NMDA 受体介导的 fEPSP 浓度依赖性降低,以响应 Schaffer 侧支刺激[1]。 MPX-004 (1 μM) 抑制 5-HT1B 拮抗剂结合 (35%),5-HT2A 激动剂结合 (31%) 和 EP4 激动剂结合 (27%)。MPX-004 (50 μM) 对小鼠视觉皮层电流切片中锥体神经元的 AMPA 受体介导的突触电流没有影响[1]。
References

[1]. Robert A Volkmann, et al. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One. 2016 Feb 1;11(2):e0148129.  

 Chemical & Physical Properties

Molecular Formula C17H15ClFN5O3S2
Molecular Weight 455.91
Top Suppliers:I want be here
Related Compounds: More...
Jdr 004
19395-50-7
tme-004
21277-98-5
MOLPORT-004-254-643
1005074-44-1
ZL-004
1015064-87-5
TP-004
1454299-21-8
TSN-004 3',5'-TIPDS-rU3',5'-O-(1,1,3,3-tetraisopropyl-1,3-dis iloxanediyl) uridine
156125-57-4
KX1-004
518058-84-9
Diindolo[3,2-b:3',2'-m]triphenodioxazinesulfonic acid, 8,18-dichloro-5,15-diethyl-5,15-dihydro-, (4-methyl-1H-imidazolyl)methyl derivs., acetates
85186-20-5
ONO-DI 004
250605-97-1
1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4,4-dimethylpentanoyl]-3-hydroxypyrrolidine-3-carboxylic acid
2172280-71-4
1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,2,3-trimethylbutanoyl]-3-hydroxypyrrolidine-3-carboxylic acid
2172294-42-5
1-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-methoxypentanoyl]-3-hydroxypyrrolidine-3-carboxylic acid
2171554-88-2
5-chloro-2-{1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropaneamido}benzoic acid
2172294-51-6
2-{N-methyl1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropaneamido}benzoic acid
2171879-27-7
2-{1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanoyl]piperidin-4-yl}acetic acid
2172436-54-1
3-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methyl-1,3-thiazol-5-yl]formamido}hexanoic acid
2172371-27-4
3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-(thiophen-2-yl)acetamido]hexanoic acid
2171726-88-6
5-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]-2,4-difluorobenzoic acid
2171161-08-1
5-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanamido]methyl}oxolane-2-carboxylic acid
2171871-86-4